Answers are grounded in this paper and cite their sources.
Atrial natriuretic polypeptide (ANP) comprises a group of potent diuretic and vasorelaxant substances synthesized and released by mammalian atrial cardiocytes. In late pregnancy, plasma ANP concentrations appear to be increased in gravidas with severe pregnancy-induced hypertension (PIH) versus normotensive parturients. Earlier gestational assessments of ANP in plasma and other fluid compartments are needed at various stages of gestation in gravidas who remain normotensive and those who become hypertensive. The present retrospective study was undertaken to determine if midgestational amniotic fluid concentrations of ANP in healthy controls and in gravidas destined to develop PIH would be significantly different and possibly predictive of later hypertensive disease. The findings in 14 gravidas who underwent midtrimester genetic amniocentesis and later developed PIH were compared with 44 matched control patients. Midgestational amniotic fluid ANP concentrations were determined to not be significantly different between the two groups of patients. Thus, it appears that this determination at the time of midtrimester genetic amniocentesis does not identify gravidas at risk for the later development of PIH
No takes yet. Share an insight, caveat, or question.
Jr. et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: